Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,764,628
-
Share change
-
-380,421
-
Total reported value
-
$112,991,911
-
Price per share
-
$6.74
-
Number of holders
-
49
-
Value change
-
-$2,942,948
-
Number of buys
-
21
-
Number of sells
-
22
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q3 2015
As of 30 Sep 2015,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,764,628 shares.
The largest 10 holders included
ProQuest Associates IV LLC, INVESTOR AB, Aisling Capital LLC, ADAGE CAPITAL PARTNERS GP LLC, Invesco Ltd., RA CAPITAL MANAGEMENT, LLC, Opaleye Management Inc., ROYCE & ASSOCIATES LLC, BlackRock Fund Advisors, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.